MedPath

Perioperative Fluid Therapy in Patients Undergoing Pancreaticoduodenectomy

Completed
Conditions
Postoperative Complications
Interventions
Other: Liberal fluid therapy
Other: Goal directed fluid therapy
Registration Number
NCT04687826
Lead Sponsor
Helsinki University Central Hospital
Brief Summary

Postoperative complication rates in patients undergoing pancreaticoduodenectomy remain high although the operation techniques have developed a lot in recent years. There is evidence that restrictive intraoperative fluid therapy could decrease postoperative complication rates but the results of the former studies have been somewhat controversial. The aim of this study is to examine whether the intraoperative and postoperative fluid therapy affect to the postoperative complication rates in patients undergoing pancreaticoduodenectomy.

Detailed Description

The study is a retrospective cohort study. The first cohort consists of patients who underwent pancreaticoduodenectomy in year 2015 when intraoperative fluid therapy were managed using goal directed fluid therapy technique. The second cohort consists of patients who underwent pancreaticoduodenectomy in year 2017 when intraoperative fluid therapy were based on the consideration of the anaesthesiologist. In 2015 most of the patients spent the first postoperative night in the ICU where the fluid management and monitoring of the urine output and vital functions were more controlled than in the normal ward. In 2017 most of the patients got in the regular ward right after the surgery. The aim of the study is to examine whether there are differences in the amounts of the intraoperative and postoperative fluids between the cohorts and does the perioperative fluid therapy affect to the complication rates.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
168
Inclusion Criteria
  • age 18 or over
  • patients who underwent pancreaticoduodenectomy in 2015 or in 2017
Exclusion Criteria
  • patients whose patient record information is insufficient

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pancreaticoduodenectomy in 2017Liberal fluid therapyPatients who underwent pancreaticoduodenectomy in 2017 got liberal intraoperative fluid therapy and most of the patients spent the first postoperative night in a regular ward.
Pancreaticoduodenectomy in 2015Goal directed fluid therapyPatients who underwent pancreaticoduodenectomy in 2015 got intraoperative fluid therapy in goal directed fluid therapy technique. Most of the patients spent the first postoperative night in ICU where the monitoring of urine output and fluid balance are more specific than in a normal ward.
Primary Outcome Measures
NameTimeMethod
Intraoperative fluid volumeThe duration of the surgery

The amount of fluid (crystalloids and albumin) patients got during the surgery

Postoperative complications (Clavien-Dindo classification)Postoperative day 0-30

The rate of severe Clavien-Dindo complications (3-5)

Secondary Outcome Measures
NameTimeMethod
Severe surgical complicationsPostoperative day 0-30

The rate of surgical complications (Clavien Dindo 3-5), without cardiopulmonary complications

Cardiopulmonary complicationsPostoperative day 0-30

The rate of cardiopulmonary complications e.g., congestive heart failure, pleural effusion, dyspnea.

Postoperative fluid balancePostoperative day 1-3

The change in postoperative fluid intake (crystalloids, colloids, blood products) and fluid output (urine output, secretion in drains etc.) in millilitres.

Pancreatic fistulasPostoperative day 0-30

The rate of severe pancreatic fistulas (grade B-C)

Postoperative fluid volumePostoperative day 0-3

The amount of fluid patients got postoperatively

Intraoperative fluid balanceThe duration of the surgery

The change in intraoperative fluid intake (crystalloids, colloids, blood products) and fluid output (urine output, blood loss, evaporation) in millilitres and ml/kg.

© Copyright 2025. All Rights Reserved by MedPath